Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IMCD NVCHIX:IMCDA 84 3-Year EPS without NRI Growth Rate is -12.50% as of Jun. 2026. GuruFocus rates CHIX:IMCDA with a GF Score™ of 84/100 and a GF Value™ of €154.01 (Significantly Undervalued). The stock has 9 warning signs investors should review. Among 1,256 Chemicals companies, IMCD NV ranks worse than 65.53% on this metric.
During the past 12 months, IMCD NV's average EPS without NRI Growth Rate was -18.60% per year.
During the past 3 years, the average EPS without NRI Growth Rate was -12.50% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 7.80% per year.
During the past 10 years, the average EPS without NRI Growth Rate was 14.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of IMCD NV was 35.40% per year. The lowest was -12.50% per year. And the median was 16.10% per year.
IMCD NV (CHIX:IMCDa) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
IMCD NV 3-Year EPS without NRI Growth Rate Related Terms
CHIX:IMCDA vs LIN, SHW, ECL: 3-Year EPS without NRI Growth Rate Comparison
For the Specialty Chemicals subindustry, IMCD NV's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IMCD NV 3-Year EPS without NRI Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, IMCD NV's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where IMCD NV's 3-Year EPS without NRI Growth Rate falls into.
IMCD NV 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of -12.50% mean?
IMCD NV (CHIX:IMCDA) has a 3-Year EPS without NRI Growth Rate of -12.50% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for IMCD NV and its competitors. According to the industry distribution chart, IMCD NV ranks #823 out of 1256 companies in the Chemicals industry, placing it in the top 65.5%.
Is IMCD NV's 3-Year EPS without NRI Growth Rate too high?
IMCD NV's current 3-Year EPS without NRI Growth Rate is -12.50%. Based on the distribution chart, IMCD NV ranks #823 out of 1256 companies in the Chemicals industry, which is below the industry midpoint. Overall, IMCD NV has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IMCD NV's 3-Year EPS without NRI Growth Rate compare to LIN and SHW?
According to the Chemicals industry distribution chart, IMCD NV ranks #823 out of 1256 companies for 3-Year EPS without NRI Growth Rate. This places IMCD NV in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Chemicals company?
A good 3-Year EPS without NRI Growth Rate depends on the Chemicals industry context. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for IMCD NV and its competitors. IMCD NV's current 3-Year EPS without NRI Growth Rate is -12.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IMCD NV stock overvalued right now?
Based on GuruFocus' analysis, IMCD NV (CHIX:IMCDA) is currently considered Significantly Undervalued. The stock's GF Value™ is €154.01, compared to a current price of €99.07 — trading 35.7% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is -12.50%. IMCD NV's overall GF Score™ is 84/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For IMCD NV (CHIX:IMCDA), the current 3-Year EPS without NRI Growth Rate is -12.50% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IMCD NV (CHIX:IMCDA) Overvalued in 2026?
Based on GuruFocus' analysis, IMCD NV stock appears to be undervalued.
The current stock price of €99.07 is trading 35.7% below its estimated GF Value™ of €154.01.
GuruFocus considers IMCD NV to be Significantly Undervalued.
Key valuation signals for CHIX:IMCDA:
3-Year EPS without NRI Growth Rate: -12.50%
GF Value™: €154.01 vs. price of €99.07 (35.7% below fair value)
No single metric tells the full story. See the CHIX:IMCDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IMCD NV is a distributor and formulator of specialty chemicals and ingredients for industrial and life-science markets. The company's product portfolio consists of two categories: Life Science, which consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition, and Home Care I&I, and the Industrial segment, which contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. The company has four operating segments: EMEA, Americas, Asia-Pacific, and Holding companies. It derives a majority of its revenue from the EMEA segment, which includes Europe, Turkiye, Israel, Egypt, the United Arab Emirates, Saudi Arabia and Africa.
84GF Score
Get the complete analysis for CHIX:IMCDA
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:IMCDA has been successfully added to your 
